Gilead Sciences
Ad
related to: emcure pharmaceuticalsamazon.in has been visited by 1M+ users in the past month
Easily Find Medication At Affordable Prices. Amazon Offers an Array Of Unique Products From Hundreds Of Brands.
Search results
We are one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. 13th Largest Pharma Company in India, In terms of Domestic Sales for MAT September 2023
Sep 30, 2023 · Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules (both softgel capsules and hard-gel capsules) and injectables.
1 day ago · Emcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 1,952 crore through the public offer. Market analysts indicate that the current GMP of the pharma company stands at Rs 260 in the unlisted market.
23 hours ago · Emcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita Thapar, a Shark Tank India investor. Thapar to sell around 12.68 lakh shares through the offer for ...
Emcure Pharmaceuticals is a fast-growing Indian pharmaceutical company engaged in developing, manufacturing & marketing a broad range of pharmaceutical products globally.
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical company with a differentiated product portfolio. With its wide range of offerings, Emcure Pharmaceuticals has cemented its presence in over 70 countries around the world.
1 day ago · Emcure Pharma IPO:The initial public offering of Emcure Pharmaceuticals Ltd, which is backed by Bain Capital, will be opened for public subscription on July 3. The price band of the Rs 1,952-crore IPO, which will conclude on July 5, has been fixed at Rs 960-Rs 1,008 per share. Emcure Pharma IPO Allotment and Listing Dates.
12 hours ago · Incorporated in 1981, Emcure Pharmaceuticals develops, manufactures, and globally markets a wide range of pharmaceutical products across several major therapeutic areas. Emcure's revenue increased by 11.33% and profit after tax (PAT) dropped by -6.1% between the financial year ending with March 31, 2024 and March 31, 2023.
Aug 5, 2021 · Emcure Pharmaceuticals, a leading pharmaceutical company engaged in developing, manufacturing & marketing a wide range of pharmaceutical products globally.
